Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEsogestrel for Bleeding on the Implant
ISRCTN10116165Phase 4Recruiting
- Sponsor
- University of Nottingham
- Start
- Sep 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of desogestrel, ethinyl estradiol and avatrombopag in menstrual disorders (2 arms), sponsored by University of Nottingham. Primary endpoint: Resolution of problem bleeding at 90 days. Started Sep 2025; status: recruiting.
02
Drugs
desogestrelethinyl estradiolavatrombopag
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on ISRCTN10116165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10116165.